Literature DB >> 10689104

Mechanism of thymocyte apoptosis induced by serum of tumor-bearing host: the molecular events involved and their inhibition by thymosin alpha-1.

R Roy1, S M Singh, A Shanker, A Sodhi.   

Abstract

The observations presented in this paper indicate that serum of Dalton's lymphoma (DL) bearing mice contained certain soluble factor(s) that augmented the induction of apoptosis in thymocytes in a time- and dose-dependent manner. DL-ascitic fluid and DL-conditioned medium could also induce apoptosis of thymocytes in vitro, though the magnitude of the same was consistently lower than that induced by serum of DL-bearing mice. It was observed that the interaction of FasL and TNFalpha with their respective receptors could trigger apoptosis in thymocytes. Elucidation of the signal transduction mechanism revealed involvement of protein tyrosine kinase, protein kinase C and ser/thr phosphatases with concomitant increase in the level of protein products of apoptosis associated genes p53, bax, bad, fas and fas ligand and cleavage of N-terminal 23 kDa fragment of Bcl-2 that exhibited Bax-like death effector properties. Further, we report, for the first time, the ability of thymosin alpha-1, an immunopotentiating thymic hormone, to antagonize apoptosis in thymocytes induced by factors present in serum of DL-bearing mice. The underlying mechanism of tumor serum induced apoptosis inhibition by thymosin alpha-1 was also analyzed. The signal transduction cascade evoked by thymosin alpha-1 involves activation of protein kinase C with a decrease in the level of protein products of proapoptotic genes like bax and bad and increase in the protein products of bcl-2 gene.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10689104     DOI: 10.1016/s0192-0561(99)00087-9

Source DB:  PubMed          Journal:  Int J Immunopharmacol        ISSN: 0192-0561


  5 in total

1.  A pilot study of the safety and efficacy of thymosin alpha 1 in augmenting immune reconstitution in HIV-infected patients with low CD4 counts taking highly active antiretroviral therapy.

Authors:  D Chadwick; J Pido-Lopez; A Pires; N Imami; F Gotch; J S Villacian; S Ravindran; N I Paton
Journal:  Clin Exp Immunol       Date:  2003-12       Impact factor: 4.330

Review 2.  Cell Senescence and Central Regulators of Immune Response.

Authors:  Sergey M Lunin; Elena G Novoselova; Olga V Glushkova; Svetlana B Parfenyuk; Tatyana V Novoselova; Maxim O Khrenov
Journal:  Int J Mol Sci       Date:  2022-04-07       Impact factor: 6.208

3.  Expression, purification and characterization of a novel soluble human thymosin alpha1 concatemer exhibited a stronger stimulation on mice lymphocytes proliferation and higher anti-tumor activity.

Authors:  Weina Li; Liqiang Song; Shouzhen Wu; Xiaochang Xue; Lu Zhang; Liqing He; Wei Han; Qing Wang; Rui Ling; Wei Zhang; Zhen Yan; Yingqi Zhang
Journal:  Int J Biol Sci       Date:  2011-05-19       Impact factor: 6.580

4.  Expression and hydroxylamine cleavage of thymosin alpha 1 concatemer.

Authors:  Liang Zhou; Zong-Teng Lai; Min-Kan Lu; Xing-Guo Gong; Yi Xie
Journal:  J Biomed Biotechnol       Date:  2008

Review 5.  Critical Neurotransmitters in the Neuroimmune Network.

Authors:  Thomas Wesley Hodo; Maria Teresa Prudente de Aquino; Akiko Shimamoto; Anil Shanker
Journal:  Front Immunol       Date:  2020-08-21       Impact factor: 7.561

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.